305 related articles for article (PubMed ID: 16730330)
1. Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo.
Atsumi A; Tomita A; Kiyoi H; Naoe T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1471-80. PubMed ID: 16730330
[TBL] [Abstract][Full Text] [Related]
2. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
3. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
4. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
5. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Shinagawa T; Ichikawa-Iwata E; Zhong S; Pandolfi PP; Ishii S
Mol Cell; 2001 Jun; 7(6):1233-43. PubMed ID: 11430826
[TBL] [Abstract][Full Text] [Related]
6. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
[TBL] [Abstract][Full Text] [Related]
7. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
[TBL] [Abstract][Full Text] [Related]
8. The fusion oncoprotein PML-RARalpha induces endoplasmic reticulum (ER)-associated degradation of N-CoR and ER stress.
Khan MM; Nomura T; Chiba T; Tanaka K; Yoshida H; Mori K; Ishii S
J Biol Chem; 2004 Mar; 279(12):11814-24. PubMed ID: 14701861
[TBL] [Abstract][Full Text] [Related]
9. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
Racanicchi S; Maccherani C; Liberatore C; Billi M; Gelmetti V; Panigada M; Rizzo G; Nervi C; Grignani F
EMBO J; 2005 Mar; 24(6):1232-42. PubMed ID: 15729358
[TBL] [Abstract][Full Text] [Related]
10. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene.
Yin L; Lazar MA
Mol Endocrinol; 2005 Jun; 19(6):1452-9. PubMed ID: 15761026
[TBL] [Abstract][Full Text] [Related]
11. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
Hoemme C; Peerzada A; Behre G; Wang Y; McClelland M; Nieselt K; Zschunke M; Disselhoff C; Agrawal S; Isken F; Tidow N; Berdel WE; Serve H; Müller-Tidow C
Blood; 2008 Mar; 111(5):2887-95. PubMed ID: 18024792
[TBL] [Abstract][Full Text] [Related]
12. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
Alenghat T; Yu J; Lazar MA
EMBO J; 2006 Sep; 25(17):3966-74. PubMed ID: 16917504
[TBL] [Abstract][Full Text] [Related]
13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
14. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
15. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.
Matsushita H; Scaglioni PP; Bhaumik M; Rego EM; Cai LF; Majid SM; Miyachi H; Kakizuka A; Miller WH; Pandolfi PP
J Exp Med; 2006 Apr; 203(4):821-8. PubMed ID: 16549595
[TBL] [Abstract][Full Text] [Related]
16. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
17. Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.
Puccetti E; Sennewald B; Fosca-Ferrara F; Boehrer S; Bianchini A; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Hematol J; 2001; 2(6):385-92. PubMed ID: 11920278
[TBL] [Abstract][Full Text] [Related]
18. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.
Sternsdorf T; Phan VT; Maunakea ML; Ocampo CB; Sohal J; Silletto A; Galimi F; Le Beau MM; Evans RM; Kogan SC
Cancer Cell; 2006 Feb; 9(2):81-94. PubMed ID: 16473276
[TBL] [Abstract][Full Text] [Related]
19. Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT.
Huang Y; Qiu J; Chen G; Dong S
Biochem Biophys Res Commun; 2008 Jan; 365(2):258-65. PubMed ID: 17991421
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
